SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS (SJIA)
Clinical trials for SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS (SJIA) explained in plain language.
Never miss a new study
Get alerted when new SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS (SJIA) trials appear
Sign up with your email to follow new studies for SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS (SJIA), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Gentler transplant approach aims to save lives from rare diseases
Disease control Recruiting nowThis study is testing a milder chemotherapy treatment given before a stem cell transplant for children and young adults with serious inherited disorders of the blood, immune system, or metabolism. The goal is to see if using lower-dose chemotherapy reduces severe side effects and…
Matched conditions: SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS (SJIA)
Phase: PHASE2 • Sponsor: Paul Szabolcs • Aim: Disease control
Last updated Apr 01, 2026 23:26 UTC
-
Real-World watch: tracking a drug for rare, debilitating fevers
Disease control Recruiting nowThis study aims to monitor the safety and effectiveness of the drug Ilaris (canakinumab) in real-world clinical settings. It will include children and adults with rare hereditary fever syndromes or a form of juvenile arthritis who are already receiving the drug as part of their s…
Matched conditions: SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS (SJIA)
Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Mar 13, 2026 15:06 UTC